Avantor, Inc. — Form 8-K
Filed July 29, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Avantor reported Q2 2026 net sales of $1,692.3M (0.5% reported growth; -0.4% organic). Adjusted EBITDA was $254.3M (15.0% margin), adjusted EPS $0.21. The company raised FY2026 organic revenue guidance from -2.5% to -0.5% up to -0.5% to +0.5%, and raised adjusted EPS guidance from $0.77–$0.83 to $0.80–$0.83. Debt reduced by $112.1M in Q2; adjusted net leverage 3.3x. VWR Distribution segment returned to organic growth (+1.7%); Bioscience & Medtech declined -5.6% organically.
Why this rating
Guidance uplift and stabilized organic decline are constructive; $112.1M debt paydown aids balance sheet. But organic sales still negative, margin compression YoY, and relative to $9.2B market cap these moves are tactical, not transformational.
See more from July 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.